Rights and permissions
About this article
Cite this article
Pegvisomant normalises markers of bone turnover in acromegaly. Inpharma Wkly. 1424, 7 (2004). https://doi.org/10.2165/00128413-200414240-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414240-00018